Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Burckhardt

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Clinical Pharmacology in Drug Development|August 15, 2019
Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy AdultsAnne Van Hecken, Björn B Burckhardt, Feras Khalil, et al.
International Journal of Antimicrobial Agents|June 22, 2023
Quantification of Plasmodium falciparum HRP-2 as an alternative method to [<sup>3</sup>H]hypoxanthine incorporation to measure the parasite reduction ratio in vitroLaís Pessanha de Carvalho, Elena Niepoth, Arbreshe Mavraj-Husejni, et al.
The Journal of Infectious Diseases|August 19, 2000
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infectionD Smith, M M Berrey, M Robertson, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Total Synthesis of the Antimycobacterial Natural Product Chlorflavonin and Analogs via a Late-Stage Ruthenium(II)-Catalyzed <i>ortho</i>-C(sp<sup>2</sup>)-H-HydroxylationAlexander Berger, Talea Knak, Anna-Lene Kiffe-Delf, et al.
Frontiers in Pharmacology|January 11, 2021
Simulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric TrialsBjoern B Burckhardt, Agnes Maria Ciplea, Anna Laven, et al.
Pharmaceutics|June 24, 2022
Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies)Stephanie Laeer, Willi Cawello, Bjoern B Burckhardt, et al.
Journal of Medicinal Chemistry|March 5, 2021
3-Hydroxy-propanamidines, a New Class of Orally Active Antimalarials Targeting Plasmodium falciparumTanja C Knaab, Jana Held, Bjoern B Burckhardt, et al.
Journal of Medicinal Chemistry|May 6, 2026
Reverse Fosmidomycin Analogs as Bisubstrate Inhibitors: Binding Mode Elucidation and Mechanistic InsightsStefan Höfmann, Sana Takada, Boris Illarionov, et al.
Journal of Medicinal Chemistry|September 8, 2025
Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial ActivitySaskia Klein, Alena Moritz, Lais Pessanha de Carvalho, et al.
Journal of Medicinal Chemistry|June 18, 2025
Development and Characterization of the First Selective Class IIb Histone Deacetylase DegradersShiyang Zhai, Irina Honin, Linda Schäker-Hübner, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology in Drug Development|August 15, 2019
Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy AdultsAnne Van Hecken, Björn B Burckhardt, Feras Khalil, et al.
International Journal of Antimicrobial Agents|June 22, 2023
Quantification of Plasmodium falciparum HRP-2 as an alternative method to [<sup>3</sup>H]hypoxanthine incorporation to measure the parasite reduction ratio in vitroLaís Pessanha de Carvalho, Elena Niepoth, Arbreshe Mavraj-Husejni, et al.
The Journal of Infectious Diseases|August 19, 2000
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infectionD Smith, M M Berrey, M Robertson, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Total Synthesis of the Antimycobacterial Natural Product Chlorflavonin and Analogs via a Late-Stage Ruthenium(II)-Catalyzed <i>ortho</i>-C(sp<sup>2</sup>)-H-HydroxylationAlexander Berger, Talea Knak, Anna-Lene Kiffe-Delf, et al.
Frontiers in Pharmacology|January 11, 2021
Simulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric TrialsBjoern B Burckhardt, Agnes Maria Ciplea, Anna Laven, et al.
Pharmaceutics|June 24, 2022
Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies)Stephanie Laeer, Willi Cawello, Bjoern B Burckhardt, et al.
Journal of Medicinal Chemistry|March 5, 2021
3-Hydroxy-propanamidines, a New Class of Orally Active Antimalarials Targeting Plasmodium falciparumTanja C Knaab, Jana Held, Bjoern B Burckhardt, et al.
Journal of Medicinal Chemistry|May 6, 2026
Reverse Fosmidomycin Analogs as Bisubstrate Inhibitors: Binding Mode Elucidation and Mechanistic InsightsStefan Höfmann, Sana Takada, Boris Illarionov, et al.
Journal of Medicinal Chemistry|September 8, 2025
Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial ActivitySaskia Klein, Alena Moritz, Lais Pessanha de Carvalho, et al.
Journal of Medicinal Chemistry|June 18, 2025
Development and Characterization of the First Selective Class IIb Histone Deacetylase DegradersShiyang Zhai, Irina Honin, Linda Schäker-Hübner, et al.
Pageof 9